Cargando…
Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001532/ https://www.ncbi.nlm.nih.gov/pubmed/32039353 http://dx.doi.org/10.1016/j.jhepr.2019.02.001 |
| _version_ | 1783494260043022336 |
|---|---|
| author | Corrigan, Margaret Haydon, Geoffrey Thompson, Fiona Rajoriya, Neil Peplow, Claire L Hubscher, Stefan G Steven, Neil Hirschfield, Gideon M Armstrong, Matthew J |
| author_facet | Corrigan, Margaret Haydon, Geoffrey Thompson, Fiona Rajoriya, Neil Peplow, Claire L Hubscher, Stefan G Steven, Neil Hirschfield, Gideon M Armstrong, Matthew J |
| author_sort | Corrigan, Margaret |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7001532 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-70015322020-02-07 Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report Corrigan, Margaret Haydon, Geoffrey Thompson, Fiona Rajoriya, Neil Peplow, Claire L Hubscher, Stefan G Steven, Neil Hirschfield, Gideon M Armstrong, Matthew J JHEP Rep Letter to the Editor Elsevier 2019-04-11 /pmc/articles/PMC7001532/ /pubmed/32039353 http://dx.doi.org/10.1016/j.jhepr.2019.02.001 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Letter to the Editor Corrigan, Margaret Haydon, Geoffrey Thompson, Fiona Rajoriya, Neil Peplow, Claire L Hubscher, Stefan G Steven, Neil Hirschfield, Gideon M Armstrong, Matthew J Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report |
| title | Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report |
| title_full | Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report |
| title_fullStr | Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report |
| title_full_unstemmed | Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report |
| title_short | Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report |
| title_sort | infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: a case report |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001532/ https://www.ncbi.nlm.nih.gov/pubmed/32039353 http://dx.doi.org/10.1016/j.jhepr.2019.02.001 |
| work_keys_str_mv | AT corriganmargaret infliximabforthetreatmentofrefractoryimmunerelatedhepatitissecondarytocheckpointinhibitorsacasereport AT haydongeoffrey infliximabforthetreatmentofrefractoryimmunerelatedhepatitissecondarytocheckpointinhibitorsacasereport AT thompsonfiona infliximabforthetreatmentofrefractoryimmunerelatedhepatitissecondarytocheckpointinhibitorsacasereport AT rajoriyaneil infliximabforthetreatmentofrefractoryimmunerelatedhepatitissecondarytocheckpointinhibitorsacasereport AT peplowclairel infliximabforthetreatmentofrefractoryimmunerelatedhepatitissecondarytocheckpointinhibitorsacasereport AT hubscherstefang infliximabforthetreatmentofrefractoryimmunerelatedhepatitissecondarytocheckpointinhibitorsacasereport AT stevenneil infliximabforthetreatmentofrefractoryimmunerelatedhepatitissecondarytocheckpointinhibitorsacasereport AT hirschfieldgideonm infliximabforthetreatmentofrefractoryimmunerelatedhepatitissecondarytocheckpointinhibitorsacasereport AT armstrongmatthewj infliximabforthetreatmentofrefractoryimmunerelatedhepatitissecondarytocheckpointinhibitorsacasereport |